Skip to main content
Erschienen in: Pediatric Radiology 4/2015

01.04.2015 | Original Article

Effectiveness of diffusion tensor imaging in assessing disease severity in Duchenne muscular dystrophy: preliminary study

verfasst von: Skorn Ponrartana, Leigh Ramos-Platt, Tishya Anne Leong Wren, Houchun Harry Hu, Thomas Gardner Perkins, Jonathan Mawlin Chia, Vicente Gilsanz

Erschienen in: Pediatric Radiology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

There is currently a lack of suitable objective endpoints to measure disease progression in Duchenne muscular dystrophy (DMD). Emerging research suggests that diffusion tensor imaging (DTI) has potential as an outcome measure for the evaluation of skeletal muscle injury.

Objective

The objective of this study was to evaluate the potential of DTI as quantitative magnetic resonance imaging (MRI) markers of disease severity in DMD.

Materials and methods

Thirteen consecutive boys (8.9 years ± 3.0 years) with DMD were evaluated using DTI. Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were compared with clinical outcome measures of manual muscle testing and MRI determinations of muscle fat fraction (MFF) in the right lower extremity.

Results

Both MRI measures of FA and ADC strongly correlated with age and muscle strength. Values for FA positively correlated with age and negatively correlated with muscle strength (r = 0.78 and −0.96; both P ≤ 0.002) while measures of ADC negatively correlated age, but positively correlated with muscle strength (r = −0.87 and 0.83; both P ≤ 0.0004). Additionally, ADC and FA strongly correlated with MFF (r = −0.891 and 0.894, respectively; both P ≤ 0.0001). Mean MMF was negatively correlated with muscle strength (r = −0.89, P = 0.0001).

Conclusion

DTI measures of muscle structure strongly correlated with muscle strength and adiposity in boys with DMD in this pilot study, although these markers may be more reflective of fat replacement rather than muscle damage in later stages of the disease. Further studies in presymptomatic younger children are needed to assess the ability of DTI to detect early changes in DMD.
Literatur
1.
Zurück zum Zitat Bushby K, Finkel R, Birnkrant DJ et al (2009) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93CrossRefPubMed Bushby K, Finkel R, Birnkrant DJ et al (2009) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93CrossRefPubMed
2.
Zurück zum Zitat Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928CrossRefPubMed Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928CrossRefPubMed
3.
Zurück zum Zitat Dubowitz V (1995) The muscular dystrophies. Muscle disorders in childhood. Saunders, London, pp 39–42 Dubowitz V (1995) The muscular dystrophies. Muscle disorders in childhood. Saunders, London, pp 39–42
4.
Zurück zum Zitat Kapsa R, Kornberg AJ, Byrne E (2003) Novel therapies for Duchenne muscular dystrophy. Lancet Neurol 2:299–310CrossRefPubMed Kapsa R, Kornberg AJ, Byrne E (2003) Novel therapies for Duchenne muscular dystrophy. Lancet Neurol 2:299–310CrossRefPubMed
5.
Zurück zum Zitat Bogdanovich S, Perkins KJ, Krag TO et al (2004) Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med (Berl) 82:102–115CrossRef Bogdanovich S, Perkins KJ, Krag TO et al (2004) Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med (Berl) 82:102–115CrossRef
6.
Zurück zum Zitat Tidball JG, Spencer MJ (2003) Skipping to new gene therapies for muscular dystrophy. Nat Med 9:997–998CrossRefPubMed Tidball JG, Spencer MJ (2003) Skipping to new gene therapies for muscular dystrophy. Nat Med 9:997–998CrossRefPubMed
7.
Zurück zum Zitat Cyrulnik SE, Fee RJ, Batchelder A et al (2008) Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc 14:853–861CrossRefPubMed Cyrulnik SE, Fee RJ, Batchelder A et al (2008) Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc 14:853–861CrossRefPubMed
8.
Zurück zum Zitat Escolar DM, Henricson EK, Mayhew J et al (2001) Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 24:787–793CrossRefPubMed Escolar DM, Henricson EK, Mayhew J et al (2001) Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 24:787–793CrossRefPubMed
10.
Zurück zum Zitat Stern LM, Caudrey DJ, Perrett LV et al (1984) Progression of muscular dystrophy assessed by computed tomography. Dev Med Child Neurol 26:569–573CrossRefPubMed Stern LM, Caudrey DJ, Perrett LV et al (1984) Progression of muscular dystrophy assessed by computed tomography. Dev Med Child Neurol 26:569–573CrossRefPubMed
11.
Zurück zum Zitat Scott OM, Hyde SA, Goddard C et al (1982) Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 5:291–301CrossRefPubMed Scott OM, Hyde SA, Goddard C et al (1982) Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 5:291–301CrossRefPubMed
12.
Zurück zum Zitat Brooke MH, Fenichel GM, Griggs RC et al (1983) Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6:91–103CrossRefPubMed Brooke MH, Fenichel GM, Griggs RC et al (1983) Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6:91–103CrossRefPubMed
13.
Zurück zum Zitat Kilmer DD, Abresch RT, Fowler WM Jr (1993) Serial manual muscle testing in Duchenne muscular dystrophy. Arch Phys Med Rehabil 74:1168–1171PubMed Kilmer DD, Abresch RT, Fowler WM Jr (1993) Serial manual muscle testing in Duchenne muscular dystrophy. Arch Phys Med Rehabil 74:1168–1171PubMed
14.
Zurück zum Zitat Brooke MH, Griggs RC, Mendell JR et al (1981) Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 4:186–197CrossRefPubMed Brooke MH, Griggs RC, Mendell JR et al (1981) Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 4:186–197CrossRefPubMed
15.
Zurück zum Zitat Pourmand R (ed) (2004) Diagnostic tests in neuromuscular disease. Saunders, Philadelphia, PA Pourmand R (ed) (2004) Diagnostic tests in neuromuscular disease. Saunders, Philadelphia, PA
16.
Zurück zum Zitat Marden FA, Connolly AM, Siegel MJ et al (2005) Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 34:140–148CrossRefPubMed Marden FA, Connolly AM, Siegel MJ et al (2005) Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 34:140–148CrossRefPubMed
17.
Zurück zum Zitat Forbes SC, Walter GA, Rooney WD et al (2013) Skeletal muscles of ambulant children with Duchenne Muscular Dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. Radiology 269:198–207CrossRefPubMedCentralPubMed Forbes SC, Walter GA, Rooney WD et al (2013) Skeletal muscles of ambulant children with Duchenne Muscular Dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. Radiology 269:198–207CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Fischmann A, Hafner P, Gloor M et al (2013) Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 260:969–974CrossRefPubMed Fischmann A, Hafner P, Gloor M et al (2013) Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 260:969–974CrossRefPubMed
19.
Zurück zum Zitat Finanger EL, Russman B, Forbes SC et al (2012) Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 23:1–10, ixCrossRefPubMedCentralPubMed Finanger EL, Russman B, Forbes SC et al (2012) Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 23:1–10, ixCrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Gaeta M, Messina S, Mileto A et al (2012) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol 41:955–961CrossRefPubMed Gaeta M, Messina S, Mileto A et al (2012) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol 41:955–961CrossRefPubMed
21.
Zurück zum Zitat Gaeta M, Scribano E, Mileto A et al (2011) Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification–a feasibility study. Radiology 259:487–494CrossRefPubMed Gaeta M, Scribano E, Mileto A et al (2011) Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification–a feasibility study. Radiology 259:487–494CrossRefPubMed
22.
Zurück zum Zitat Kim HK, Laor T, Horn PS et al (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255:899–908CrossRefPubMed Kim HK, Laor T, Horn PS et al (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255:899–908CrossRefPubMed
23.
Zurück zum Zitat Wren TA, Bluml S, Tseng-Ong L et al (2008) Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 190:W8–12CrossRefPubMed Wren TA, Bluml S, Tseng-Ong L et al (2008) Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 190:W8–12CrossRefPubMed
24.
Zurück zum Zitat Hollingsworth KG, Garrood P, Eagle M et al (2013) MR imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve 48:586–588CrossRefPubMed Hollingsworth KG, Garrood P, Eagle M et al (2013) MR imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve 48:586–588CrossRefPubMed
25.
Zurück zum Zitat Kan HE, Scheenen TW, Wohlgemuth M et al (2009) Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 19:357–362CrossRefPubMed Kan HE, Scheenen TW, Wohlgemuth M et al (2009) Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 19:357–362CrossRefPubMed
26.
Zurück zum Zitat Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 15:456–467CrossRefPubMed Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 15:456–467CrossRefPubMed
27.
Zurück zum Zitat Heemskerk AM, Strijkers GJ, Vilanova A et al (2005) Determination of mouse skeletal muscle architecture using three-dimensional diffusion tensor imaging. Magn Reson Med 53:1333–1340CrossRefPubMed Heemskerk AM, Strijkers GJ, Vilanova A et al (2005) Determination of mouse skeletal muscle architecture using three-dimensional diffusion tensor imaging. Magn Reson Med 53:1333–1340CrossRefPubMed
28.
Zurück zum Zitat Zaraiskaya T, Kumbhare D, Noseworthy MD (2006) Diffusion tensor imaging in evaluation of human skeletal muscle injury. J Magn Reson Imaging 24:402–408CrossRefPubMed Zaraiskaya T, Kumbhare D, Noseworthy MD (2006) Diffusion tensor imaging in evaluation of human skeletal muscle injury. J Magn Reson Imaging 24:402–408CrossRefPubMed
29.
Zurück zum Zitat Heemskerk AM, Damon DM (2007) Diffusion tensor MRI assessment of human skeletal muscle architecture. Curr Med Imaging Rev 3:152–160CrossRef Heemskerk AM, Damon DM (2007) Diffusion tensor MRI assessment of human skeletal muscle architecture. Curr Med Imaging Rev 3:152–160CrossRef
30.
Zurück zum Zitat Zhang J, Zhang G, Morrison B et al (2008) Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy. Exp Neurol 212:448–457CrossRefPubMedCentralPubMed Zhang J, Zhang G, Morrison B et al (2008) Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy. Exp Neurol 212:448–457CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Kendall HO, Kendall FP, Wadsworth GE (1971) Muscles, testing and function. Williams and Wilkins, Baltimore, MD Kendall HO, Kendall FP, Wadsworth GE (1971) Muscles, testing and function. Williams and Wilkins, Baltimore, MD
32.
Zurück zum Zitat Ponrartana S, Andrade K, Wren TA et al (2014) Repeatability of diffusion tensor imaging for the evaluation of lower extremity skeletal muscle. AJR Am J Roentgenol 202:W567–574CrossRefPubMed Ponrartana S, Andrade K, Wren TA et al (2014) Repeatability of diffusion tensor imaging for the evaluation of lower extremity skeletal muscle. AJR Am J Roentgenol 202:W567–574CrossRefPubMed
33.
Zurück zum Zitat Reeder SB, McKenzie CA, Pineda AR et al (2007) Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25:644–652CrossRefPubMed Reeder SB, McKenzie CA, Pineda AR et al (2007) Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25:644–652CrossRefPubMed
34.
Zurück zum Zitat Bley TA, Wieben O, Francois CJ et al (2010) Fat and water magnetic resonance imaging. J Magn Reson Imaging 31:4–18CrossRefPubMed Bley TA, Wieben O, Francois CJ et al (2010) Fat and water magnetic resonance imaging. J Magn Reson Imaging 31:4–18CrossRefPubMed
35.
Zurück zum Zitat Kim HK, Laor T, Horn PS et al (2010) Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol 11:304–311CrossRefPubMedCentralPubMed Kim HK, Laor T, Horn PS et al (2010) Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol 11:304–311CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat Kermarrec E, Budzik JF, Khalil C et al (2010) In vivo diffusion tensor imaging and tractography of human thigh muscles in healthy subjects. AJR Am J Roentgenol 195:W352–356CrossRefPubMed Kermarrec E, Budzik JF, Khalil C et al (2010) In vivo diffusion tensor imaging and tractography of human thigh muscles in healthy subjects. AJR Am J Roentgenol 195:W352–356CrossRefPubMed
37.
Zurück zum Zitat Sinha S, Sinha U, Edgerton VR (2006) In vivo diffusion tensor imaging of the human calf muscle. J Magn Reson Imaging 24:182–190CrossRefPubMed Sinha S, Sinha U, Edgerton VR (2006) In vivo diffusion tensor imaging of the human calf muscle. J Magn Reson Imaging 24:182–190CrossRefPubMed
38.
Zurück zum Zitat Galban CJ, Maderwald S, Uffmann K et al (2005) A diffusion tensor imaging analysis of gender differences in water diffusivity within human skeletal muscle. NMR Biomed 18:489–498CrossRefPubMed Galban CJ, Maderwald S, Uffmann K et al (2005) A diffusion tensor imaging analysis of gender differences in water diffusivity within human skeletal muscle. NMR Biomed 18:489–498CrossRefPubMed
39.
Zurück zum Zitat Budzik JF, Le Thuc V, Demondion X et al (2007) In vivo MR tractography of thigh muscles using diffusion imaging: initial results. Eur Radiol 17:3079–3085CrossRefPubMed Budzik JF, Le Thuc V, Demondion X et al (2007) In vivo MR tractography of thigh muscles using diffusion imaging: initial results. Eur Radiol 17:3079–3085CrossRefPubMed
40.
Zurück zum Zitat Qi J, Olsen NJ, Price RR et al (2008) Diffusion-weighted imaging of inflammatory myopathies: polymyositis and dermatomyositis. J Magn Reson Imaging 27:212–217CrossRefPubMed Qi J, Olsen NJ, Price RR et al (2008) Diffusion-weighted imaging of inflammatory myopathies: polymyositis and dermatomyositis. J Magn Reson Imaging 27:212–217CrossRefPubMed
41.
Zurück zum Zitat Williams SE, Heemskerk AM, Welch EB et al (2013) Quantitative effects of inclusion of fat on muscle diffusion tensor MRI measurements. J Magn Reson Imaging 38:1292–1297CrossRefPubMed Williams SE, Heemskerk AM, Welch EB et al (2013) Quantitative effects of inclusion of fat on muscle diffusion tensor MRI measurements. J Magn Reson Imaging 38:1292–1297CrossRefPubMed
Metadaten
Titel
Effectiveness of diffusion tensor imaging in assessing disease severity in Duchenne muscular dystrophy: preliminary study
verfasst von
Skorn Ponrartana
Leigh Ramos-Platt
Tishya Anne Leong Wren
Houchun Harry Hu
Thomas Gardner Perkins
Jonathan Mawlin Chia
Vicente Gilsanz
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 4/2015
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-014-3187-6

Weitere Artikel der Ausgabe 4/2015

Pediatric Radiology 4/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.